Canon BioMedical, Inc., and Canon U.S. Life Sciences, Inc., are subsidiaries of Canon U.S.A, Inc., and focused on empowering the biomedical research and healthcare communities by developing, manufacturing and marketing innovative technologies and solutions. The technologies and solutions developed will help enable clinicians and scientists to improve our health and advance science. Canon BioMedical will pursue and deliver innovative solutions through the use of existing and emerging Canon technology, as well as strategic partnerships.
Canon U.S.A., Inc., is a leading provider of consumer, business-to-business, and industrial digital imaging solutions to the United States and to Latin America and the Caribbean markets. With approximately $29 billion in global revenue, its parent company, Canon Inc. (NYSE:CAJ), ranks third overall in U.S. patents granted in 2016† and is one of Fortune Magazine's World's Most Admired Companies in 2016. Canon U.S.A. is committed to the highest level of customer satisfaction and loyalty, providing 100 percent U.S.-based consumer service and support for all of the products it distributes. Canon U.S.A. is dedicated to its Kyosei philosophy of social and environmental responsibility. In 2014, the Canon Americas Headquarters secured LEED® Gold certification, a recognition for the design, construction, operations and maintenance of high-performance green buildings. To keep apprised of the latest news from Canon U.S.A., sign up for the Company's RSS news feed by visiting www.usa.canon.com/rss
and follow us on Twitter @CanonUSA. For media inquiries, please contact firstname.lastname@example.org
† Based on weekly patent counts issued by United States Patent and Trademark Office.
All referenced product names, and other marks, are trademarks of their respective owners.
We are an EEO/AA employer. Minority/Female/Individuals with Disabilities/Protected Veterans.